Results 61 to 70 of about 10,606 (259)

Impella Versus Intra‐Aortic Balloon Pump in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: An Observational Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. Although Impella or intra‐aortic balloon pump (IABP) is frequently used for left ventricular unloading (LVU) during VA‐ECMO ...
Ilhwan Yeo   +12 more
doaj   +1 more source

Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience

open access: yesFrontiers in Cardiovascular Medicine, 2023
IntroductionCardiogenic shock (CS) is a severe syndrome with poor prognosis. Short-term mechanical circulatory support with Impella devices has emerged as an increasingly therapeutic option, unloading the failing left ventricle (LV) and improving ...
M. V. Matassini   +17 more
doaj   +1 more source

Microaxial pump‐supported coronary surgery without CPB to optimize outcome in severely impaired left ventricles

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Cardiopulmonary bypass (CPB) is the standard approach for coronary artery bypass grafting (CABG) in advanced ischaemic cardiomyopathy. Microaxial pump support has been envisioned to allow for beating‐heart CABG without CPB (MPCAB), thereby avoiding CPB‐inherent complications.
Anna Kathrin Assmann   +5 more
wiley   +1 more source

Lower extremity artery thromboembolism during removal of Impella after repair for ventricular septal rupture: A case report

open access: yesSAGE Open Medical Case Reports
Although the anticoagulant complications of Impella are well known, the timing of heparin administration when using Impella immediately after open heart surgery has not been established.
Yoshifumi Itoda   +9 more
doaj   +1 more source

Pitfalls of anesthetic management with the Impella® 5.0 device: a case series

open access: yesJA Clinical Reports, 2020
Background Impella® is an antegrade left ventricular assist device with a pump catheter in the left ventricle. We report three cases in which we experienced some pitfalls with circulatory management during Impella placement due to new-onset aortic ...
Naoshi Hotta   +3 more
doaj   +1 more source

Asistencias ventriculares de corta duración. Revisión bibliográfica y cuidados de enfermería [PDF]

open access: yes, 2016
Los dispositivos de asistencia ventricular (DAV) son sistemas de bombeo que proporcionan apoyo mecánico y aportan soporte hemodinámico a un corazón de un paciente en estado crítico, incapaz de bombear de forma adecuada la sangre y mantener correctamente ...
Donis Aranda, Marta
core  

DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock

open access: yesESC Heart Failure, EarlyView.
Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner   +10 more
wiley   +1 more source

Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation

open access: yesESC Heart Failure, EarlyView.
In the context of patients with severe heart failure, it is crucial to ensure adequate preconditioning before considering the implantation of dLVAD. Although several types of mechanical circulatory assist devices are available and all offer a significant advantage, the present study suggests that the higher the flow rate provided by the Impella®, the ...
Marta L. Medina   +32 more
wiley   +1 more source

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients

open access: yesFrontiers in Cardiovascular Medicine, 2020
Background: In-hospital mortality in acute myocardial infarction-related cardiogenic shock (AMI-CS) remains high. The only adequately powered randomized trial showed no benefit of routine use of the intra-aortic balloon pump in AMI-CS.
Andreas Schäfer   +9 more
doaj   +1 more source

Acute myocarditis according to age: Presentation, management and early outcomes

open access: yesESC Heart Failure, EarlyView.
MIS, multisystem inflammatory syndrome; MRE, myocarditis‐related events (within 30 days included all‐cause death, cardiogenic shock, cardiac arrest, ventricular arrhythmias or complete AV block). Abstract Aims Acute myocarditis (AM) is a rare but severe disease affecting patients of all ages. Large multicentric studies comparing children and adults are
Clément Karsenty   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy